Archive

Archive for the ‘Fibrocell Science’ Category

Fibrocell Science (OTCBB: FCSC.OB), FDA approves BLA for laViv, personalized aesthetic cell therapy

June 22nd, 2011 No comments

laVív® (azficel-T) is the first and only personalized aesthetic cell therapy approved by the FDA Read more…

Categories: BLA Approval, Fibrocell Science, NASDAQ: FSC.OB

Fibrocell Science, Autologous cell therapy

March 8th, 2011 No comments

Developing a method for converting dermal fibroblasts into regenerative, functional human cell types for applications in autologous cell therapy Read more…

Categories: Autologous cell therapy, Fibrocell Science, Stem Cell Research